Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD2 is a transmembrane glycoprotein and cell adhesion molecule primarily expressed on T cells and NK cells. It plays critical roles in cell adhesion and signal transduction during immune responses, acting as a co-stimulatory molecule. CD2 interacts with LFA-3/CD58 or CD48, facilitating stable contact during immune synapse formation. Monoclonal antibodies targeting CD2 have been developed for modulating undesired immune responses such as autoimmune diseases or transplant rejection.
Monoclonal antibodies targeting CD2 modulate immune responses by blocking adhesion and/or signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Lymphocyte Surface Antigen CD2 (CD2).